e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Value of proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD: Initial experience
R. El-Helbawy, R. Yasin, M. Shawky (Menoufiya, Egypt)
Source:
Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Session:
Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Session type:
Thematic Poster Session
Number:
2508
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. El-Helbawy, R. Yasin, M. Shawky (Menoufiya, Egypt). Value of proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD: Initial experience. Eur Respir J 2013; 42: Suppl. 57, 2508
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006
The study of proton magnetic resonance spectroscopy on hippocampus in rats with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Sildenafil treatment in COPD does not affect stroke volume or exercise capacity
Source: Eur Respir J 2008; 31: 759-764
Year: 2008
Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study
Source: Eur Respir J 2004; 24: 980-986
Year: 2004
Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Determination of mild emphysema on computed tomography and chest X-ray
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Delayed gas filling imaged in asthma patients using hyperpolarised
3
He MRI
Source: International Congress 2014 – Functional imaging
Year: 2014
Nonlinear dynamics of heart rate variability in patients with chronic obstructive pulmonary disease and changes after 4-week rehabilitation
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014
Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Structural brain changes in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
The acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function study
Source: Eur Respir J 2012; 40: 298-305
Year: 2012
Impact of hypertension on cerebral microvascular structure in obstructive sleep apnoea patients:a diffusion magnetic-resonance imaging study.
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019
Cerebral cortical dysfunction in chronic obstructive pulmonary disease: role of transcranial magnetic stimulation
Source: Eur Respir J 2006; 28: Suppl. 50, 63s
Year: 2006
Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009
Factors of cardiac dysfunction in advanced COPD
Source: International Congress 2014 – Functional imaging
Year: 2014
Characterisation of acinar airspace involvement in patients with asthma using hyperpolarised
3
He magnetic resonance and quantitative computed tomography
Source: International Congress 2014 – Functional imaging
Year: 2014
COPD and hypogonadism
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014
Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Physical activity and moderate exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept